Herein, we have conducted a single-institute study with a larger cohort in order to evaluate the interaction between six oncogenic drivers and the PD-L1 status amongst patients with NSCLC, and focused on whether individual oncogenic drivers have different impacts on the PD-L1 expression. Here, CD274 is linked to non-small cell lung carcinoma.